Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1982-04-05
1984-08-07
Shippen, Michael L.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
562560, A61K 31195, C07C12912
Patent
active
044643950
ABSTRACT:
Antihypertensive compound 176 is a natural product amino acid produced by cultivation of a Streptomyces species under controlled aerobic fermentation conditions. The product is also shown to inhibit angiotensin converting enzyme.
REFERENCES:
patent: 3679742 (1972-07-01), Umezawa
patent: 3743580 (1973-07-01), Umezawa
patent: 3809759 (1974-05-01), Bocher
patent: 3915918 (1975-10-01), Wille
patent: 3967770 (1976-08-01), Bumpus et al.
patent: 4061542 (1977-12-01), Demny
patent: 4173704 (1979-11-01), Ondetti et al.
patent: 4216209 (1980-08-01), Bellini et al.
patent: 4220642 (1980-09-01), Said et al.
Linek Ernest J.
Merck & Co. , Inc.
Mitri Salvatore C.
Shippen Michael L.
LandOfFree
Antihypertensive compound 176 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antihypertensive compound 176, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antihypertensive compound 176 will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-603701